FTC hits Amneal, Impax and Endo with antitrust suit
28-01-2021
Amneal and Impax merge to become ‘fifth largest’ generics company
19-10-2017
Allergan settles Restasis patent suit with InnoPharma, leaving three defendants
13-10-2017
Jirsak / shutterstock.com
Dublin-based pharmaceutical company Allergan has revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Allergan, Adamas, Amneal, Forest, Namzaric, FDA, ANDA, patent
